Novo Nordisk hires US pharma veteran as Trump pricing pressure mounts

Core Insights - Novo Nordisk has appointed Greg Miley as the new head of corporate affairs, indicating a strategic move to strengthen its leadership in response to increasing pressures in the obesity drug market [1] Company Developments - The appointment of Greg Miley, a U.S. pharmaceutical executive, reflects Novo Nordisk's commitment to enhancing its corporate affairs amid growing scrutiny and competition in the obesity treatment sector [1]